Found: 3
Select item for more details and to access through your institution.
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 351, doi. 10.1016/j.cllc.2020.12.008
- By:
- Publication type:
- Article
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory "FoRECATT" study.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1583, doi. 10.1007/s00262-020-02788-1
- By:
- Publication type:
- Article
Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1196, doi. 10.3390/cancers12051196
- By:
- Publication type:
- Article